In recent developments within the biopharmaceutical sector, DuPont has taken a significant step forward by unveiling its latest offering. The introduction of Liveo Pharma TPE Ultra-Low Temp Tubing marks an innovative expansion of DuPont’s product line, specifically targeted at the stringent demands of cryogenic cell and gene therapy workflows. This new thermoplastic elastomer (TPE) tubing, designed to perform under extreme cold-chain conditions, represents a notable advancement in maintaining operational efficiency and product integrity even at temperatures plummeting to –86°C. Critical for applications requiring extreme cold resistance, this tubing retains its flexibility and durability under such harsh conditions. The innovation addresses the sector’s growing need for materials that offer toughness, ductility, and resistance to bending and crushing at temperatures down to –80°C.
Advancements in Cryogenic Tubing
The introduction of the Liveo Pharma TPE Ultra‑Low Temp Tubing aligns with an increasing reliance on technologies that can sustain their efficacy in cryogenic environments, pivotal in cell and gene therapies. This tubing not only exhibits high pumpability and minimal spallation but also offers strong chemical resistance, crucial for maintaining aseptic conditions across biopharma workflows. Ensuring regulatory compliance, the tubing is produced in an ISO Class 7 cleanroom. It meets the rigorous USP Class VI and extractables requirements of USP , conforms with elemental impurity limits under USP , and has been tested for biocompatibility in accordance with several ISO 10993 standards. By fulfilling these standards, DuPont reiterates its commitment to quality and safety, which are critical components in the biopharmaceutical sector. This compliance is particularly relevant in developing single-use components that simplify the sterilization process, reducing cross-contamination risks.
Enhancing DuPont’s Biopharmaceutical Offerings
DuPont’s entry into this niche area expands its current lineup of biopharmaceutical solutions, complementing its well-known silicone-based Liveo tubing and over-molded products. This strategic move is designed to fortify DuPont’s position in the fiercely competitive market of single-use technologies for biopharmaceutical applications. As the industry shifts towards solutions that emphasize safety and user-friendliness, DuPont’s introduction of TPE tubing stands out as a vital component, offering facilities products that are both dependable and efficient. This initiative not only highlights DuPont’s ability to meet evolving market demands but also underscores its dedication to innovation. Amid growing competition, DuPont’s continued reliability with the Liveo brand offers a competitive advantage, underscoring the trusted quality that professionals in the industry have come to expect. The Liveo Pharma TPE Ultra-Low Temp Tubing enhances performance in cryogenic environments and bolsters DuPont’s esteemed reputation among advanced biopharma solution providers. As the demand for single-use components rises, this tubing release demonstrates DuPont’s mission to provide cutting-edge products, poised to support the industry’s future requirements. With an increased focus on compliance and safety, these advancements are likely to influence future trends in biopharmaceutical processing, paving the way for more robust and reliable solutions.
